Novo Nordisk A/S
A Senior Market Access Manager at Novo Nordisk shapes therapy access for chronic diseases in Mexico across public and private payers. The role involves executing regional market access strategies, managing tender processes, and developing value propositions to secure formulary inclusion. It requires deep knowledge of the Mexican healthcare system while collaborating with medical, sales, and government affairs teams.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
4% below the average for this role
Field Market Access Manager
AstraZeneca
Field Market Access Manager
AstraZeneca
Market Access Manager
Pfizer
Associate Director, Market Access & Corporate Affairs
State of Indiana
Market Access Manager - BBU
AstraZeneca
Senior Director, Global Market Access, Diabetes Portfolio, Novo Nordisk
State of Indiana